{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T03:02:33Z","timestamp":1697079753012},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T00:00:00Z","timestamp":1384905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s10157-013-0914-5","type":"journal-article","created":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T03:00:09Z","timestamp":1384830009000},"page":"821-830","source":"Crossref","is-referenced-by-count":5,"title":["Effect of aliskiren in chronic kidney disease patients with refractory hypertension undergoing hemodialysis: a randomized controlled multicenter study"],"prefix":"10.1007","volume":"18","author":[{"given":"Satoru","family":"Kuriyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichiro","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sugano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,20]]},"reference":[{"issue":"21","key":"914_CR1","first-page":"1983","volume":"2003","author":"World Health Organization, International Society of Hypertension Writing Group","year":"2003","unstructured":"World Health Organization, International Society of Hypertension Writing Group. World Health Organization (WHO)\/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;2003(21):1983\u201392.","journal-title":"J Hypertens"},{"key":"914_CR2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1291\/hypres.27.755","volume":"27","author":"T Ohkubo","year":"2004","unstructured":"Ohkubo T, Obara T, Funahashi J, Kikuya M, Asayama K, Metoki H, Oikawa T, Takahashi H, Hashimoto J, Totsune K, Imai Y, J-HOME Study Group. Control of blood pressure as measured at home and office, and comparison with physicians\u2019 assessment of control among treated hypertensive patients in Japan: first report of the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Hypertens Res. 2004;27:755\u201363.","journal-title":"Hypertens Res"},{"key":"914_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/hr.2008.31","volume":"32","author":"T Ogihara","year":"2009","unstructured":"Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H, On behalf of The Japanese Society of Hypertension Committee. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res. 2009;32:3\u2013107.","journal-title":"Hypertens Res"},{"key":"914_CR4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/08037059309077521","volume":"2","author":"B Waeber","year":"2001","unstructured":"Waeber B. Achieving blood pressure targets in the management of hypertension. Blood Press Suppl. 2001;2:6\u201312.","journal-title":"Blood Press Suppl"},{"key":"914_CR5","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, The National High Blood Pressure Education Program Coordinating Committee, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee: the seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560\u201372.","journal-title":"JAMA"},{"issue":"5","key":"914_CR6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1744-9987.2012.01088.x","volume":"16","author":"H Hirakata","year":"2012","unstructured":"Hirakata H, Nitta K, Inaba M, Shoji T, Fujii H, Kobayashi S, Tabei K, Joki N, Hase H, Nishimura M, Ozaki S, Ikari Y, Kumada Y, Tsuruya K, Fujimoto S, Inoue T, Yokoi H, Hirata S, Shimamoto K, Kugiyama K, Akiba T, Iseki K, Tsubakihara Y, Tomo T, Alozawa T. Japanese Society for Dialysis Therapy guidelines for management of cardiovascular disease in patients on chronic dialysis. Ther Apher Dial. 2012;16(5):387\u2013435.","journal-title":"Ther Apher Dial"},{"issue":"2","key":"914_CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1470320309104662","volume":"10","author":"PS Sever","year":"2009","unstructured":"Sever PS, Grandman AH, Azizi M. Managing cardiovascular risk: the potential of direct renin inhibition. J Renin Angiotensin Aldosterone Syst. 2009;10(2):65\u201376.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"914_CR8","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2165\/00003495-200767120-00008","volume":"67","author":"JE Frampton","year":"2007","unstructured":"Frampton JE, Curran MP. Aliskiren: a review of its use in the management of hypertension. Drugs. 2007;67:1767\u201392.","journal-title":"Drugs"},{"key":"914_CR9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/sj.ki.5002732","volume":"73","author":"FC Luft","year":"2007","unstructured":"Luft FC, Weinberger MH. Antihypertensive therapy with aliskiren. Kidney Int. 2007;73:679\u201383.","journal-title":"Kidney Int"},{"key":"914_CR10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1345\/aph.1H549","volume":"41","author":"BW Tassell Van","year":"2007","unstructured":"Van Tassell BW, Munger MA. Aliskiren for renin inhibition: a new class of antihypertensives. Ann Pharmacother. 2007;41:456\u201364.","journal-title":"Ann Pharmacother"},{"key":"914_CR11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrd2550","volume":"7","author":"C Jensen","year":"2008","unstructured":"Jensen C, Herold P, Brunner HR. Aliskiren: the first renin inhibitor for clinical treatment. Nat Rev Drug Discov. 2008;7:399\u2013410.","journal-title":"Nat Rev Drug Discov"},{"key":"914_CR12","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(06)69442-7","volume":"368","author":"JA Staessen","year":"2006","unstructured":"Staessen JA, Li Y, Richart T. Oral renin inhibitors. Lancet. 2006;368:1449\u201356 (erratum Lancet 2006;368:2124).","journal-title":"Lancet"},{"key":"914_CR13","doi-asserted-by":"crossref","first-page":"209A","DOI":"10.1161\/01.HYP.11.3_Pt_2.II67","volume":"11","author":"ED Frohlich","year":"1988","unstructured":"Frohlich ED, Grim C, Labarthe DR, Maxell MH, Perloff D, Weidman WH. Recommendation for human blood pressure determination by sphygmomanometers. Hypertension. 1988;11:209A\u201322A.","journal-title":"Hypertension"},{"key":"914_CR14","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","unstructured":"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002;288:2981\u201397.","journal-title":"JAMA"},{"issue":"9426","key":"914_CR15","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","volume":"363","author":"S Julius","year":"2004","unstructured":"Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A, VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363(9426):2022\u201331.","journal-title":"Lancet"},{"issue":"23","key":"914_CR16","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"K Jamerson","year":"2008","unstructured":"Jamerson K, Weber MA, Bakris GL, Dahl\u00f6f B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ, ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417\u201328. doi: 10.1056\/NEJMoa0806182 .","journal-title":"N Engl J Med"},{"key":"914_CR17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/hr.2010.238","volume":"34","author":"Y Morishita","year":"2011","unstructured":"Morishita Y, Hanawa S, Chinda J, Iimura O, Tsunematsu S, Kusano E. Effect of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patient with hypertension. Hypertens Res. 2011;34:308\u201313.","journal-title":"Hypertens Res"},{"issue":"1","key":"914_CR18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2185\/jrm.6.26","volume":"6","author":"Y Maeda","year":"2011","unstructured":"Maeda Y, Araki Y, Uno T, Nishigaki K, Inaba N. Successful treatment of hypertension in anuric hemodialysis patients with a direct rennin inhibitor, aliskiren. J Rural Med. 2011;6(1):26\u201331.","journal-title":"J Rural Med"},{"key":"914_CR19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.HYP.0000179573.91016.3f","volume":"46","author":"B Pilz","year":"2005","unstructured":"Pilz B, Shagdarsuren E, Wellner M, Fiebeler A, Dechend R, Gratze P, Meiners S, Feldman DL, Webb RL, Garrelds IM, Jan Dancer AH, Luft AC, Muller DN. Aliskiren, a human rennin inhibitor, ameriorates cardiac and renal damage in double-transgenic rats. Hypertension. 2005;46:569\u201376.","journal-title":"Hypertension"},{"key":"914_CR20","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/HYPERTENSIONAHA.107.103143","volume":"51","author":"R Fisher","year":"2008","unstructured":"Fisher R, Dechend R, Quadri F, Markovic M, Feldt S, Herse F, Park J-K, Gapelyuk A, Schwarz I, Zacharzowsky UB, Plehm R, Safak E, Heuser A, Schirdeman A, Luft FC, Schunck W-H, Muller DN. Dietary n-3 polysaturated fatty acids and direct rennin inhibition improve electrical remodeling in a model of high human renin hypertension. Hypertension. 2008;51:540\u20136.","journal-title":"Hypertension"},{"key":"914_CR21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCHEARTFAILURE.107.740704","volume":"1","author":"JJV McMurray","year":"2008","unstructured":"McMurray JJV, Pitt B, Latini R, et al. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure. Circ Heart Fail. 2008;1:17\u201324.","journal-title":"Circ Heart Fail"},{"key":"914_CR22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ehj.2003.10.030","volume":"25","author":"R Latini","year":"2004","unstructured":"Latini R, Masson S, Anand I, Salio M, Hester A, Judd D, Berlera S, Maggioni SB, Tognoni G, Cohn JN, For the Val-HeFT investigators. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J. 2004;25:292\u20139.","journal-title":"Eur Heart J"},{"key":"914_CR23","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/01.hjh.0000165625.79933.9a","volume":"23","author":"P Gosse","year":"2005","unstructured":"Gosse P. Left ventricular hypertrophy as a predictor of cardiovascular risk. J Hypertens Suppl. 2005;23:S27\u201333.","journal-title":"J Hypertens Suppl"},{"key":"914_CR24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.HYP.0000170140.36633.8f","volume":"46","author":"CR Filippi de","year":"2005","unstructured":"de Filippi CR, Selinger SL, Maynard S, Christensen RH. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure markers. Hypertension. 2005;46:118\u201323.","journal-title":"Hypertension"},{"key":"914_CR25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.amjcard.2007.07.058","volume":"101","author":"D Goei","year":"2008","unstructured":"Goei D, Schouten O, Boersma E, Welten GM, Dunkelgren M, Lindemans J, van Gestel YR, Hoeks SE, Bax JJ, Poldermanns D. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery. Am J Cardiol. 2008;101:122\u20136.","journal-title":"Am J Cardiol"},{"key":"914_CR26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.amjhyper.2007.04.001","volume":"20","author":"JE Sealey","year":"2007","unstructured":"Sealey JE, Laragh JH. Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness. Am J Hypertens. 2007;20:587\u201397.","journal-title":"Am J Hypertens"},{"key":"914_CR27","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/HJH.0b013e3282ef45e9","volume":"25","author":"J Menard","year":"2007","unstructured":"Menard J, Azizi M. The difficult conception, birth and delivery of a renin inhibitor: controversies around aliskiren. J Hypertens. 2007;25:1775\u201382.","journal-title":"J Hypertens"},{"key":"914_CR28","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1161\/CIRCULATIONAHA.108.767202","volume":"117","author":"NDL Fisher","year":"2008","unstructured":"Fisher NDL, Jan Dancer AH, Nussberger J, Dole WP, Hollenberg NK. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Circulation. 2008;117:3199\u2013205.","journal-title":"Circulation"},{"key":"914_CR29","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1007\/s00125-010-1789-6","volume":"53","author":"F Persson","year":"2010","unstructured":"Persson F, Rossing P, Reinhard H, Juhl T, Stehouwer CDA, Schalkwijk C, Dancer AHJ, Boomsma F, Frandsen E, Parving H-H. Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial. Diabetologia. 2010;53:1576\u201380.","journal-title":"Diabetologia"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0914-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-013-0914-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0914-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:44:40Z","timestamp":1559112280000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-013-0914-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,20]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["914"],"URL":"https:\/\/doi.org\/10.1007\/s10157-013-0914-5","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,20]]}}}